nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—mammary gland—lung cancer	0.0409	0.212	CbGeAlD
Framycetin—CXCR4—respiratory system—lung cancer	0.0272	0.141	CbGeAlD
Framycetin—CXCR4—epithelium—lung cancer	0.0228	0.118	CbGeAlD
Framycetin—CXCR4—bronchus—lung cancer	0.0224	0.116	CbGeAlD
Framycetin—Ototoxicity—Vinorelbine—lung cancer	0.0222	0.0633	CcSEcCtD
Framycetin—Nephrotoxicity—Teniposide—lung cancer	0.0221	0.063	CcSEcCtD
Framycetin—Ulcerative keratitis—Erlotinib—lung cancer	0.0204	0.0582	CcSEcCtD
Framycetin—CXCR4—trachea—lung cancer	0.0201	0.104	CbGeAlD
Framycetin—CXCR4—cardiac atrium—lung cancer	0.0189	0.0981	CbGeAlD
Framycetin—Ototoxicity—Cisplatin—lung cancer	0.0166	0.0474	CcSEcCtD
Framycetin—CXCR4—bone marrow—lung cancer	0.016	0.0829	CbGeAlD
Framycetin—Ototoxicity—Paclitaxel—lung cancer	0.0149	0.0426	CcSEcCtD
Framycetin—CXCR4—lung—lung cancer	0.0145	0.0751	CbGeAlD
Framycetin—Nerve injury—Paclitaxel—lung cancer	0.0137	0.0391	CcSEcCtD
Framycetin—Ototoxicity—Docetaxel—lung cancer	0.0126	0.0361	CcSEcCtD
Framycetin—Malabsorption—Methotrexate—lung cancer	0.0126	0.036	CcSEcCtD
Framycetin—Nephropathy toxic—Teniposide—lung cancer	0.0122	0.0349	CcSEcCtD
Framycetin—Nephrotoxicity—Cisplatin—lung cancer	0.0105	0.0299	CcSEcCtD
Framycetin—CXCR4—lymph node—lung cancer	0.00989	0.0513	CbGeAlD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—SOX2—lung cancer	0.00833	0.0182	CbGpPWpGaD
Framycetin—Nephropathy toxic—Vinorelbine—lung cancer	0.00775	0.0221	CcSEcCtD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—NCAM1—lung cancer	0.00762	0.0167	CbGpPWpGaD
Framycetin—CXCR4—Early Phase of HIV Life Cycle—CD4—lung cancer	0.00761	0.0166	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—ITGB1—lung cancer	0.00756	0.0165	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—OXTR—lung cancer	0.00693	0.0152	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ALDOA—lung cancer	0.00677	0.0148	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PXN—lung cancer	0.0064	0.014	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ABCG2—lung cancer	0.00639	0.014	CbGpPWpGaD
Framycetin—Nephropathy toxic—Gemcitabine—lung cancer	0.00623	0.0178	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—FGR—lung cancer	0.0062	0.0136	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—TF—lung cancer	0.00594	0.013	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—FGFR1—lung cancer	0.00592	0.0129	CbGpPWpGaD
Framycetin—Nephropathy toxic—Cisplatin—lung cancer	0.0058	0.0166	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ENO1—lung cancer	0.0057	0.0125	CbGpPWpGaD
Framycetin—Secondary infection—Doxorubicin—lung cancer	0.00539	0.0154	CcSEcCtD
Framycetin—Nephropathy toxic—Etoposide—lung cancer	0.00532	0.0152	CcSEcCtD
Framycetin—Nephropathy toxic—Paclitaxel—lung cancer	0.00521	0.0149	CcSEcCtD
Framycetin—Sensitisation—Doxorubicin—lung cancer	0.00443	0.0127	CcSEcCtD
Framycetin—Impaired healing—Methotrexate—lung cancer	0.00423	0.0121	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ABCB1—lung cancer	0.00399	0.00873	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—SRC—lung cancer	0.00384	0.0084	CbGpPWpGaD
Framycetin—CXCR4—HIV Life Cycle—PPIA—lung cancer	0.00383	0.00837	CbGpPWpGaD
Framycetin—Erythema—Pemetrexed—lung cancer	0.00379	0.0108	CcSEcCtD
Framycetin—CXCR4—S1P3 pathway—VEGFA—lung cancer	0.00374	0.00818	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—KDR—lung cancer	0.00372	0.00814	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—MAPK3—lung cancer	0.00354	0.00774	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—KIT—lung cancer	0.00343	0.0075	CbGpPWpGaD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—MMP9—lung cancer	0.00342	0.00748	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—TERT—lung cancer	0.00341	0.00747	CbGpPWpGaD
Framycetin—Infection—Crizotinib—lung cancer	0.00336	0.00959	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—GRM8—lung cancer	0.00334	0.00731	CbGpPWpGaD
Framycetin—Viral infection—Paclitaxel—lung cancer	0.00332	0.00946	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—HIF1A—lung cancer	0.00326	0.00714	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—OXTR—lung cancer	0.00326	0.00713	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—GRP—lung cancer	0.00326	0.00713	CbGpPWpGaD
Framycetin—Anaphylactic shock—Pemetrexed—lung cancer	0.00309	0.00883	CcSEcCtD
Framycetin—Infection—Pemetrexed—lung cancer	0.00307	0.00877	CcSEcCtD
Framycetin—Infection—Gefitinib—lung cancer	0.00305	0.00871	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—CREBBP—lung cancer	0.00267	0.00584	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—PPIA—lung cancer	0.00264	0.00578	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—GNG11—lung cancer	0.00257	0.00563	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—OXTR—lung cancer	0.00255	0.00559	CbGpPWpGaD
Framycetin—Swelling—Etoposide—lung cancer	0.00251	0.00717	CcSEcCtD
Framycetin—Infection—Teniposide—lung cancer	0.00249	0.0071	CcSEcCtD
Framycetin—Swelling—Paclitaxel—lung cancer	0.00246	0.00703	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL8—lung cancer	0.00242	0.00529	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—ANXA1—lung cancer	0.0024	0.00525	CbGpPWpGaD
Framycetin—CXCR4—S1P3 pathway—AKT1—lung cancer	0.00239	0.00522	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—GIPR—lung cancer	0.00238	0.0052	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CG—lung cancer	0.00237	0.00519	CbGpPWpGaD
Framycetin—Diarrhoea—Crizotinib—lung cancer	0.00232	0.00661	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—ADCY1—lung cancer	0.00231	0.00507	CbGpPWpGaD
Framycetin—Hypersensitivity—Pemetrexed—lung cancer	0.00228	0.0065	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—APP—lung cancer	0.00227	0.00498	CbGpPWpGaD
Framycetin—Hypersensitivity—Gefitinib—lung cancer	0.00226	0.00646	CcSEcCtD
Framycetin—Erythema—Erlotinib—lung cancer	0.00225	0.00642	CcSEcCtD
Framycetin—Pruritus—Pemetrexed—lung cancer	0.00219	0.00624	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	0.00219	0.00479	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	0.00219	0.00479	CbGpPWpGaD
Framycetin—Pruritus—Gefitinib—lung cancer	0.00217	0.0062	CcSEcCtD
Framycetin—Vomiting—Crizotinib—lung cancer	0.00215	0.00614	CcSEcCtD
Framycetin—Diarrhoea—Pemetrexed—lung cancer	0.00212	0.00604	CcSEcCtD
Framycetin—Diarrhoea—Gefitinib—lung cancer	0.0021	0.006	CcSEcCtD
Framycetin—Swelling—Docetaxel—lung cancer	0.00209	0.00596	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—ERCC2—lung cancer	0.00204	0.00447	CbGpPWpGaD
Framycetin—CXCR4—G alpha (i) signalling events—ANXA1—lung cancer	0.00202	0.00443	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—GRM8—lung cancer	0.00202	0.00443	CbGpPWpGaD
Framycetin—Nausea—Crizotinib—lung cancer	0.00201	0.00574	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—JUN—lung cancer	0.00197	0.00431	CbGpPWpGaD
Framycetin—Vomiting—Pemetrexed—lung cancer	0.00197	0.00561	CcSEcCtD
Framycetin—Vomiting—Gefitinib—lung cancer	0.00195	0.00558	CcSEcCtD
Framycetin—Erythema—Vinorelbine—lung cancer	0.00195	0.00555	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—APP—lung cancer	0.00192	0.0042	CbGpPWpGaD
Framycetin—Anaphylactic shock—Topotecan—lung cancer	0.00186	0.0053	CcSEcCtD
Framycetin—Hypersensitivity—Teniposide—lung cancer	0.00185	0.00527	CcSEcCtD
Framycetin—Infection—Topotecan—lung cancer	0.00184	0.00526	CcSEcCtD
Framycetin—Nausea—Pemetrexed—lung cancer	0.00184	0.00524	CcSEcCtD
Framycetin—Nausea—Gefitinib—lung cancer	0.00183	0.00521	CcSEcCtD
Framycetin—Infection—Erlotinib—lung cancer	0.00182	0.00521	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—MTOR—lung cancer	0.00182	0.00398	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CB—lung cancer	0.00182	0.00398	CbGpPWpGaD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—EP300—lung cancer	0.00182	0.00397	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—CD4—lung cancer	0.00181	0.00397	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—lung cancer	0.00178	0.00389	CbGpPWpGaD
Framycetin—Pruritus—Teniposide—lung cancer	0.00177	0.00506	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—AVP—lung cancer	0.00177	0.00387	CbGpPWpGaD
Framycetin—Viral infection—Doxorubicin—lung cancer	0.00175	0.005	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—VEGFA—lung cancer	0.00172	0.00376	CbGpPWpGaD
Framycetin—Diarrhoea—Teniposide—lung cancer	0.00171	0.00489	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—OXTR—lung cancer	0.00167	0.00364	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—GRP—lung cancer	0.00167	0.00364	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.00161	0.00352	CbGpPWpGaD
Framycetin—Vomiting—Teniposide—lung cancer	0.00159	0.00455	CcSEcCtD
Framycetin—Anaphylactic shock—Vinorelbine—lung cancer	0.00159	0.00453	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—MMP9—lung cancer	0.00158	0.00346	CbGpPWpGaD
Framycetin—Infection—Vinorelbine—lung cancer	0.00158	0.0045	CcSEcCtD
Framycetin—Erythema—Gemcitabine—lung cancer	0.00156	0.00446	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—GNG11—lung cancer	0.00156	0.00341	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.00153	0.00334	CbGpPWpGaD
Framycetin—Nausea—Teniposide—lung cancer	0.00149	0.00425	CcSEcCtD
Framycetin—Erythema—Cisplatin—lung cancer	0.00146	0.00416	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—SRC—lung cancer	0.00146	0.00319	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—ERCC2—lung cancer	0.00141	0.00309	CbGpPWpGaD
Framycetin—Hypersensitivity—Vinblastine—lung cancer	0.00141	0.00402	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—STAT3—lung cancer	0.0014	0.00307	CbGpPWpGaD
Framycetin—Hypersensitivity—Topotecan—lung cancer	0.00137	0.0039	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—GIPR—lung cancer	0.00134	0.00294	CbGpPWpGaD
Framycetin—Pruritus—Topotecan—lung cancer	0.00131	0.00375	CcSEcCtD
Framycetin—Anaphylactic shock—Irinotecan—lung cancer	0.00131	0.00374	CcSEcCtD
Framycetin—Erythema—Paclitaxel—lung cancer	0.00131	0.00374	CcSEcCtD
Framycetin—Diarrhoea—Vinblastine—lung cancer	0.00131	0.00373	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—PTHLH—lung cancer	0.0013	0.00285	CbGpPWpGaD
Framycetin—Infection—Irinotecan—lung cancer	0.0013	0.00371	CcSEcCtD
Framycetin—Pruritus—Erlotinib—lung cancer	0.0013	0.00371	CcSEcCtD
Framycetin—Anaphylactic shock—Gemcitabine—lung cancer	0.00128	0.00364	CcSEcCtD
Framycetin—Diarrhoea—Topotecan—lung cancer	0.00127	0.00363	CcSEcCtD
Framycetin—Infection—Gemcitabine—lung cancer	0.00127	0.00362	CcSEcCtD
Framycetin—Diarrhoea—Erlotinib—lung cancer	0.00126	0.00359	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—CD4—lung cancer	0.00123	0.0027	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—ANXA1—lung cancer	0.00123	0.00268	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GIPR—lung cancer	0.00122	0.00267	CbGpPWpGaD
Framycetin—Vomiting—Vinblastine—lung cancer	0.00122	0.00347	CcSEcCtD
Framycetin—Anaphylactic shock—Cisplatin—lung cancer	0.00119	0.00339	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.00119	0.0026	CbGpPWpGaD
Framycetin—Infection—Cisplatin—lung cancer	0.00118	0.00337	CcSEcCtD
Framycetin—Vomiting—Topotecan—lung cancer	0.00118	0.00337	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—POMC—lung cancer	0.00118	0.00257	CbGpPWpGaD
Framycetin—Hypersensitivity—Vinorelbine—lung cancer	0.00117	0.00334	CcSEcCtD
Framycetin—Vomiting—Erlotinib—lung cancer	0.00117	0.00333	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—APP—lung cancer	0.00116	0.00254	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRM8—lung cancer	0.00114	0.0025	CbGpPWpGaD
Framycetin—Nausea—Vinblastine—lung cancer	0.00114	0.00324	CcSEcCtD
Framycetin—Pruritus—Vinorelbine—lung cancer	0.00112	0.00321	CcSEcCtD
Framycetin—Erythema—Docetaxel—lung cancer	0.00111	0.00317	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—PIK3CA—lung cancer	0.00111	0.00242	CbGpPWpGaD
Framycetin—Nausea—Topotecan—lung cancer	0.0011	0.00315	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—AKT1—lung cancer	0.0011	0.0024	CbGpPWpGaD
Framycetin—Nausea—Erlotinib—lung cancer	0.00109	0.00311	CcSEcCtD
Framycetin—Anaphylactic shock—Etoposide—lung cancer	0.00109	0.00311	CcSEcCtD
Framycetin—Diarrhoea—Vinorelbine—lung cancer	0.00109	0.0031	CcSEcCtD
Framycetin—Infection—Etoposide—lung cancer	0.00108	0.00309	CcSEcCtD
Framycetin—Anaphylactic shock—Paclitaxel—lung cancer	0.00107	0.00305	CcSEcCtD
Framycetin—Infection—Paclitaxel—lung cancer	0.00106	0.00303	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GRM8—lung cancer	0.00104	0.00227	CbGpPWpGaD
Framycetin—CXCR4—Disease—PGAM1—lung cancer	0.00103	0.00225	CbGpPWpGaD
Framycetin—Vomiting—Vinorelbine—lung cancer	0.00101	0.00288	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—POMC—lung cancer	0.000991	0.00217	CbGpPWpGaD
Framycetin—Hypersensitivity—Irinotecan—lung cancer	0.000965	0.00275	CcSEcCtD
Framycetin—CXCR4—Disease—SDC4—lung cancer	0.000961	0.0021	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AXL—lung cancer	0.000951	0.00208	CbGpPWpGaD
Framycetin—Nausea—Vinorelbine—lung cancer	0.000943	0.00269	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—OXTR—lung cancer	0.000941	0.00206	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—GRP—lung cancer	0.000941	0.00206	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL8—lung cancer	0.000909	0.00199	CbGpPWpGaD
Framycetin—Anaphylactic shock—Docetaxel—lung cancer	0.000906	0.00258	CcSEcCtD
Framycetin—CXCR4—CXCR4-mediated signaling events—AKT1—lung cancer	0.000905	0.00198	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—AVP—lung cancer	0.000903	0.00198	CbGpPWpGaD
Framycetin—Pruritus—Gemcitabine—lung cancer	0.000903	0.00258	CcSEcCtD
Framycetin—Infection—Docetaxel—lung cancer	0.0009	0.00257	CcSEcCtD
Framycetin—Diarrhoea—Irinotecan—lung cancer	0.000896	0.00256	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—GNG11—lung cancer	0.000881	0.00193	CbGpPWpGaD
Framycetin—Hypersensitivity—Cisplatin—lung cancer	0.000876	0.0025	CcSEcCtD
Framycetin—Diarrhoea—Gemcitabine—lung cancer	0.000873	0.00249	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—OXTR—lung cancer	0.000855	0.00187	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—GRP—lung cancer	0.000855	0.00187	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CD4—lung cancer	0.000852	0.00186	CbGpPWpGaD
Framycetin—CXCR4—Disease—SKI—lung cancer	0.000848	0.00186	CbGpPWpGaD
Framycetin—Vomiting—Irinotecan—lung cancer	0.000833	0.00238	CcSEcCtD
Framycetin—CXCR4—Disease—B4GALT5—lung cancer	0.000823	0.0018	CbGpPWpGaD
Framycetin—Diarrhoea—Cisplatin—lung cancer	0.000814	0.00232	CcSEcCtD
Framycetin—Vomiting—Gemcitabine—lung cancer	0.000811	0.00232	CcSEcCtD
Framycetin—Hypersensitivity—Etoposide—lung cancer	0.000803	0.00229	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—GNG11—lung cancer	0.0008	0.00175	CbGpPWpGaD
Framycetin—Erythema—Methotrexate—lung cancer	0.0008	0.00228	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—ADCY1—lung cancer	0.000792	0.00173	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000788	0.00172	CbGpPWpGaD
Framycetin—Hypersensitivity—Paclitaxel—lung cancer	0.000787	0.00225	CcSEcCtD
Framycetin—Nausea—Irinotecan—lung cancer	0.000778	0.00222	CcSEcCtD
Framycetin—Pruritus—Etoposide—lung cancer	0.000771	0.0022	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL8—lung cancer	0.000767	0.00168	CbGpPWpGaD
Framycetin—Nausea—Gemcitabine—lung cancer	0.000758	0.00216	CcSEcCtD
Framycetin—Vomiting—Cisplatin—lung cancer	0.000756	0.00216	CcSEcCtD
Framycetin—Pruritus—Paclitaxel—lung cancer	0.000756	0.00216	CcSEcCtD
Framycetin—Diarrhoea—Etoposide—lung cancer	0.000745	0.00213	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—COL4A2—lung cancer	0.00074	0.00162	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PTHLH—lung cancer	0.000736	0.00161	CbGpPWpGaD
Framycetin—CXCR4—Disease—PXN—lung cancer	0.000736	0.00161	CbGpPWpGaD
Framycetin—Diarrhoea—Paclitaxel—lung cancer	0.000731	0.00209	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—GIPR—lung cancer	0.000721	0.00158	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKR1C1—lung cancer	0.000721	0.00158	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADCY1—lung cancer	0.000719	0.00157	CbGpPWpGaD
Framycetin—Nausea—Cisplatin—lung cancer	0.000706	0.00202	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PPP2R1B—lung cancer	0.000701	0.00153	CbGpPWpGaD
Framycetin—Vomiting—Etoposide—lung cancer	0.000693	0.00198	CcSEcCtD
Framycetin—Erythema—Doxorubicin—lung cancer	0.000692	0.00198	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—ANXA1—lung cancer	0.000692	0.00152	CbGpPWpGaD
Framycetin—Vomiting—Paclitaxel—lung cancer	0.000679	0.00194	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SDC4—lung cancer	0.000673	0.00147	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PTHLH—lung cancer	0.000669	0.00146	CbGpPWpGaD
Framycetin—Hypersensitivity—Docetaxel—lung cancer	0.000667	0.0019	CcSEcCtD
Framycetin—CXCR4—Disease—NPPA—lung cancer	0.000663	0.00145	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DUSP3—lung cancer	0.000659	0.00144	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—APP—lung cancer	0.000656	0.00144	CbGpPWpGaD
Framycetin—Anaphylactic shock—Methotrexate—lung cancer	0.000653	0.00186	CcSEcCtD
Framycetin—Infection—Methotrexate—lung cancer	0.000648	0.00185	CcSEcCtD
Framycetin—CXCR4—Disease—PPIA—lung cancer	0.000648	0.00142	CbGpPWpGaD
Framycetin—Nausea—Etoposide—lung cancer	0.000647	0.00185	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—RHEB—lung cancer	0.000647	0.00142	CbGpPWpGaD
Framycetin—CXCR4—Disease—ALDOA—lung cancer	0.000642	0.00141	CbGpPWpGaD
Framycetin—Pruritus—Docetaxel—lung cancer	0.000641	0.00183	CcSEcCtD
Framycetin—Nausea—Paclitaxel—lung cancer	0.000635	0.00181	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—ANXA1—lung cancer	0.000629	0.00138	CbGpPWpGaD
Framycetin—Diarrhoea—Docetaxel—lung cancer	0.00062	0.00177	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—GRM8—lung cancer	0.000613	0.00134	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.00061	0.00133	CbGpPWpGaD
Framycetin—CXCR4—Disease—ADCY1—lung cancer	0.000607	0.00133	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—POMC—lung cancer	0.0006	0.00131	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—APP—lung cancer	0.000596	0.0013	CbGpPWpGaD
Framycetin—CXCR4—Disease—ENO2—lung cancer	0.000595	0.0013	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SKI—lung cancer	0.000594	0.0013	CbGpPWpGaD
Framycetin—CXCR4—Disease—PPP2R1B—lung cancer	0.000591	0.00129	CbGpPWpGaD
Framycetin—CXCR4—Disease—SMARCA4—lung cancer	0.000591	0.00129	CbGpPWpGaD
Framycetin—Vomiting—Docetaxel—lung cancer	0.000576	0.00164	CcSEcCtD
Framycetin—Anaphylactic shock—Doxorubicin—lung cancer	0.000565	0.00161	CcSEcCtD
Framycetin—Infection—Doxorubicin—lung cancer	0.000561	0.0016	CcSEcCtD
Framycetin—CXCR4—Disease—ENO1—lung cancer	0.000541	0.00118	CbGpPWpGaD
Framycetin—Nausea—Docetaxel—lung cancer	0.000538	0.00154	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—PXN—lung cancer	0.000516	0.00113	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AVP—lung cancer	0.00051	0.00112	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GRP—lung cancer	0.000505	0.0011	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKR1C1—lung cancer	0.000505	0.0011	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—OXTR—lung cancer	0.000505	0.0011	CbGpPWpGaD
Framycetin—CXCR4—Disease—APP—lung cancer	0.000503	0.0011	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGF9—lung cancer	0.000499	0.00109	CbGpPWpGaD
Framycetin—Hypersensitivity—Methotrexate—lung cancer	0.000481	0.00137	CcSEcCtD
Framycetin—CXCR4—Disease—JUNB—lung cancer	0.000476	0.00104	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—GNG11—lung cancer	0.000473	0.00103	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CXCL8—lung cancer	0.000464	0.00102	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AVP—lung cancer	0.000463	0.00101	CbGpPWpGaD
Framycetin—Pruritus—Methotrexate—lung cancer	0.000462	0.00132	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—VEGFC—lung cancer	0.00045	0.000985	CbGpPWpGaD
Framycetin—Diarrhoea—Methotrexate—lung cancer	0.000447	0.00127	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—ADCY1—lung cancer	0.000425	0.00093	CbGpPWpGaD
Framycetin—CXCR4—Disease—FOXO3—lung cancer	0.000417	0.000913	CbGpPWpGaD
Framycetin—Hypersensitivity—Doxorubicin—lung cancer	0.000416	0.00119	CcSEcCtD
Framycetin—Vomiting—Methotrexate—lung cancer	0.000415	0.00118	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—SMARCA4—lung cancer	0.000414	0.000906	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PPP2R1B—lung cancer	0.000414	0.000906	CbGpPWpGaD
Framycetin—Pruritus—Doxorubicin—lung cancer	0.0004	0.00114	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—HSPB1—lung cancer	0.000399	0.000874	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTHLH—lung cancer	0.000395	0.000864	CbGpPWpGaD
Framycetin—Nausea—Methotrexate—lung cancer	0.000388	0.00111	CcSEcCtD
Framycetin—Diarrhoea—Doxorubicin—lung cancer	0.000387	0.0011	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—ANXA1—lung cancer	0.000371	0.000813	CbGpPWpGaD
Framycetin—CXCR4—Disease—HES1—lung cancer	0.00037	0.000809	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FLT1—lung cancer	0.00036	0.000787	CbGpPWpGaD
Framycetin—Vomiting—Doxorubicin—lung cancer	0.000359	0.00103	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CG—lung cancer	0.000356	0.00078	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NOTCH3—lung cancer	0.000352	0.00077	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APP—lung cancer	0.000352	0.00077	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGF9—lung cancer	0.000349	0.000764	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERCC2—lung cancer	0.000346	0.000756	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—POMC—lung cancer	0.000339	0.000742	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB3—lung cancer	0.000338	0.00074	CbGpPWpGaD
Framycetin—Nausea—Doxorubicin—lung cancer	0.000336	0.000958	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—JUNB—lung cancer	0.000333	0.00073	CbGpPWpGaD
Framycetin—CXCR4—Disease—TERT—lung cancer	0.000324	0.000709	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CG—lung cancer	0.000324	0.000708	CbGpPWpGaD
Framycetin—CXCR4—Disease—FGFR1—lung cancer	0.000315	0.000688	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CD—lung cancer	0.000313	0.000686	CbGpPWpGaD
Framycetin—CXCR4—Disease—HIF1A—lung cancer	0.00031	0.000678	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—POMC—lung cancer	0.000308	0.000674	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STK11—lung cancer	0.000303	0.000663	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6R—lung cancer	0.0003	0.000658	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOA1—lung cancer	0.000299	0.000654	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FOXO3—lung cancer	0.000292	0.000639	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAP2K1—lung cancer	0.000286	0.000627	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CD—lung cancer	0.000284	0.000623	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AVP—lung cancer	0.000274	0.000599	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CB—lung cancer	0.000273	0.000598	CbGpPWpGaD
Framycetin—CXCR4—Disease—APC—lung cancer	0.000273	0.000597	CbGpPWpGaD
Framycetin—CXCR4—Disease—KIT—lung cancer	0.000273	0.000597	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGF—lung cancer	0.00027	0.00059	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1R—lung cancer	0.000264	0.000577	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CXCL8—lung cancer	0.000262	0.000574	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HES1—lung cancer	0.000259	0.000567	CbGpPWpGaD
Framycetin—CXCR4—Disease—BRAF—lung cancer	0.000257	0.000562	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—RAF1—lung cancer	0.000254	0.000556	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6R—lung cancer	0.000253	0.000555	CbGpPWpGaD
Framycetin—CXCR4—Disease—CREBBP—lung cancer	0.000253	0.000554	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—lung cancer	0.000251	0.000549	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CB—lung cancer	0.000248	0.000543	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAP2K1—lung cancer	0.000242	0.000529	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CD—lung cancer	0.00024	0.000525	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL8—lung cancer	0.000238	0.000521	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB3—lung cancer	0.000237	0.000518	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—lung cancer	0.000228	0.000498	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TERT—lung cancer	0.000227	0.000497	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGFR1—lung cancer	0.00022	0.000482	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HIF1A—lung cancer	0.000217	0.000475	CbGpPWpGaD
Framycetin—CXCR4—Disease—MDM2—lung cancer	0.000215	0.00047	CbGpPWpGaD
Framycetin—CXCR4—Disease—RAF1—lung cancer	0.000214	0.000469	CbGpPWpGaD
Framycetin—CXCR4—Disease—ERBB2—lung cancer	0.000212	0.000464	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APOA1—lung cancer	0.000209	0.000458	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTOR—lung cancer	0.000209	0.000458	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CB—lung cancer	0.000209	0.000458	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD4—lung cancer	0.000209	0.000457	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KDR—lung cancer	0.000208	0.000454	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTGS2—lung cancer	0.000207	0.000454	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CG—lung cancer	0.000191	0.000418	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KIT—lung cancer	0.000191	0.000418	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—APC—lung cancer	0.000191	0.000418	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—NRAS—lung cancer	0.000191	0.000418	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGF—lung cancer	0.000189	0.000413	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—MAPK3—lung cancer	0.000183	0.000401	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—POMC—lung cancer	0.000182	0.000398	CbGpPWpGaD
Framycetin—CXCR4—Disease—CDKN1A—lung cancer	0.000181	0.000396	CbGpPWpGaD
Framycetin—CXCR4—Disease—PTEN—lung cancer	0.000181	0.000396	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BRAF—lung cancer	0.00018	0.000393	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6R—lung cancer	0.000177	0.000388	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CREBBP—lung cancer	0.000177	0.000388	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—EGFR—lung cancer	0.000174	0.000381	CbGpPWpGaD
Framycetin—CXCR4—Disease—EP300—lung cancer	0.000172	0.000377	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAP2K1—lung cancer	0.000169	0.00037	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CD—lung cancer	0.000168	0.000368	CbGpPWpGaD
Framycetin—CXCR4—Disease—SRC—lung cancer	0.000168	0.000367	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PIK3CA—lung cancer	0.000166	0.000364	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—KRAS—lung cancer	0.000165	0.00036	CbGpPWpGaD
Framycetin—CXCR4—Disease—STAT3—lung cancer	0.000162	0.000354	CbGpPWpGaD
Framycetin—CXCR4—Disease—NRAS—lung cancer	0.000161	0.000353	CbGpPWpGaD
Framycetin—CXCR4—Disease—MAPK3—lung cancer	0.000154	0.000338	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PIK3CA—lung cancer	0.000151	0.000331	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MDM2—lung cancer	0.000151	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—lung cancer	0.00015	0.000329	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RAF1—lung cancer	0.00015	0.000328	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ERBB2—lung cancer	0.000148	0.000325	CbGpPWpGaD
Framycetin—CXCR4—Disease—EGFR—lung cancer	0.000147	0.000322	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MTOR—lung cancer	0.000146	0.000321	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CB—lung cancer	0.000146	0.000321	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL8—lung cancer	0.000141	0.000308	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—HRAS—lung cancer	0.00014	0.000306	CbGpPWpGaD
Framycetin—CXCR4—Disease—KRAS—lung cancer	0.000139	0.000304	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—AKT1—lung cancer	0.000136	0.000298	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CASP3—lung cancer	0.000135	0.000295	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—lung cancer	0.000135	0.000294	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—lung cancer	0.000134	0.000293	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCND1—lung cancer	0.000131	0.000287	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—JUN—lung cancer	0.000131	0.000286	CbGpPWpGaD
Framycetin—CXCR4—Disease—PIK3CA—lung cancer	0.000128	0.000279	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MMP9—lung cancer	0.000127	0.000279	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CDKN1A—lung cancer	0.000127	0.000278	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTEN—lung cancer	0.000127	0.000277	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—AKT1—lung cancer	0.000123	0.00027	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EP300—lung cancer	0.000121	0.000264	CbGpPWpGaD
Framycetin—CXCR4—Disease—HRAS—lung cancer	0.000118	0.000258	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SRC—lung cancer	0.000117	0.000257	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—VEGFA—lung cancer	0.000114	0.00025	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—STAT3—lung cancer	0.000113	0.000248	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NRAS—lung cancer	0.000113	0.000247	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—lung cancer	0.000113	0.000247	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MAPK3—lung cancer	0.000108	0.000237	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—lung cancer	0.000105	0.00023	CbGpPWpGaD
Framycetin—CXCR4—Disease—AKT1—lung cancer	0.000104	0.000228	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—EGFR—lung cancer	0.000103	0.000225	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KRAS—lung cancer	9.72e-05	0.000213	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PIK3CA—lung cancer	8.93e-05	0.000195	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TP53—lung cancer	8.64e-05	0.000189	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—HRAS—lung cancer	8.26e-05	0.000181	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—lung cancer	7.91e-05	0.000173	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—AKT1—lung cancer	7.29e-05	0.00016	CbGpPWpGaD
